Characterization of the contactin 5 protein and its risk‐associated polymorphic variant throughout the Alzheimer's disease spectrum-Reference-Cited by-同舟云学术

Characterization of the contactin 5 protein and its risk‐associated polymorphic variant throughout the Alzheimer's disease spectrum

Published:2022-12-30 Issue: Volume: Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Dauar Marina Tedeschi¹²³⁴^ORCID,Labonté Anne¹²,Picard Cynthia¹²,Miron Justin¹²³,Rosa‐Neto Pedro¹²³⁵,Zetterberg Henrik⁶⁷⁸⁹¹⁰,Blennow Kaj⁶⁷,Villeneuve Sylvia¹²³⁵,Poirier Judes¹²³⁵

Affiliation:

1. Douglas Mental Health University Institute Montréal Canada

2. Centre for the Studies in the Prevention of Alzheimer's Douglas Mental Health University Institute Montréal Canada

3. McGill University Montréal Canada

4. CAPES Foundation Ministry of Education of Brazil Brasília Brazil

5. Department of Psychiatry McGill University Montréal Canada

6. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy University of Gothenburg Gothenburg Sweden

7. Clinical Neurochemistry Laboratory Sahlgrenska University Hospital Mölndal Sweden

8. Department of Neurodegenerative Disease UCL Institute of Neurology London UK

9. UK Dementia Research Institute at UCL London UK

10. Hong Kong Center for Neurodegenerative Diseases Hong Kong China

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12868

Reference43 articles.

1. To what degree is late life cognitive decline driven by age-related neuropathologies?

2. The development and convergence of co-pathologies in Alzheimer’s disease

3. Alzheimer's Disease: The Amyloid Cascade Hypothesis

4. Classification and basic pathology of Alzheimer disease

5. Assessment of the genetic variance of late-onset Alzheimer's disease